Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer
about
Multigene testing of moderate-risk genes: be mindful of the missensePALB2: research reaching to clinical outcomes for women with breast cancerSMRT compounds correct nonsense mutations in primary immunodeficiency and other genetic modelsComputational and statistical approaches to analyzing variants identified by exome sequencingClinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevancePALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSRare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancersRare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening studyRare mutations in XRCC2 increase the risk of breast cancerRare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening studyVariant ataxia-telangiectasia presenting as primary-appearing dystonia in Canadian Mennonites.Detecting statistical interaction between somatic mutational events and germline variation from next-generation sequence data.A fine-scale dissection of the DNA double-strand break repair machinery and its implications for breast cancer therapy.Detecting differential allelic expression using high-resolution melting curve analysis: application to the breast cancer susceptibility gene CHEK2.Low levels of ATM in breast cancer patients with clinical radiosensitivity.Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls.RAD51 and breast cancer susceptibility: no evidence for rare variant association in the Breast Cancer Family Registry study.A probabilistic method for identifying rare variants underlying complex traitsA PALB2 mutation associated with high risk of breast cancer.Genome-wide small RNA sequencing and gene expression analysis reveals a microRNA profile of cancer susceptibility in ATM-deficient human mammary epithelial cells.ATM gene mutations in sporadic breast cancer patients from Brazil.Inherited predisposition to breast cancer among African American women.An optimal weighted aggregated association test for identification of rare variants involved in common diseases.Growing recognition of the role for rare missense substitutions in breast cancer susceptibilityCommon variants at the 9q22.33, 14q13.3 and ATM loci, and risk of differentiated thyroid cancer in the Cuban population.A probabilistic disease-gene finder for personal genomes.Increasing power of groupwise association test with likelihood ratio testRare variants in the ATM gene and risk of breast cancerENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genesPrevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer.Underexpression and abnormal localization of ATM products in ataxia telangiectasia patients bearing ATM missense mutationsAssociation of three SNPs in TOX3 and breast cancer risk: Evidence from 97275 cases and 128686 controls.ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry.Evaluation of NTF4 as a causative gene for primary open-angle glaucoma.Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiencyp53 centrosomal localization diagnoses ataxia-telangiectasia homozygotes and heterozygotes.Tumour morphology of early-onset breast cancers predicts breast cancer risk for first-degree relatives: the Australian Breast Cancer Family Registry.Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families.
P2860
Q24658557-C5A9EEF4-8815-4A40-AB0D-EF32D4701894Q26751309-B6EBCDCE-E700-4FEF-8EE7-585360C8D56FQ27007538-7659B666-3814-4361-9BE9-9C8E89D5E7B0Q27024342-3B44B8B4-8C4D-4BCE-A0BC-351C139A60E8Q27853333-FEE5E7C8-30F2-48AD-A106-0C20BC534345Q28074414-C3872B89-94B5-4A1F-83D0-0FA2133BEF74Q28584533-CA3C3F6D-3EDD-4E1C-BCBB-CD4596F34554Q28652056-35177685-815A-47A8-96F9-E33AEE01886AQ28652308-AF8DDFBE-E9F5-4707-A585-AC61E05B9D64Q28730692-06B0F33E-F9CA-44A0-8EF3-12702018F85CQ28743906-EE7CC4F2-CE33-4A8A-91AF-91C72CF8F05DQ30505486-16D1FC77-D8B8-4776-BB70-D319627B8ED7Q30705769-D51D36E0-A66E-4C62-8C11-D7FC419B3298Q33698648-3558CF98-2989-43D4-A597-32E40067664FQ33898712-149D50EC-7418-4BED-A0EA-7EEB087CAF80Q34036288-AD75ABBC-5B4D-4A38-9E27-65C69B77DA4FQ34123806-BFF5A11A-6061-4CE3-8D0A-477BED2AC909Q34540638-8307AD52-0446-452F-B278-FEE0E5F4A623Q34569912-F446C373-0561-4A35-91F2-4A7F512E9DF8Q34613667-ED52712E-974E-4D7B-890E-1FDBCB9A128BQ34760829-EC8B6887-177E-456D-95AA-EAC38258095DQ34983335-0A587BD1-F0CA-4AB6-AF13-513766C733E6Q34983596-6736F722-DFFC-4ECF-B8D6-5ED32FDAACA8Q35060063-F0A87DD5-47C3-41FB-AA6D-E0FD6867602CQ35106767-139C8323-4B5B-4271-9144-7CA0440CFED2Q35163365-0834C951-9077-4327-B52D-9C27632160B4Q35195981-49471E02-26CD-4EE5-863D-935D4FE51B58Q35550128-6C45E6B9-D97C-485F-B2E7-70D33B5B439AQ35608690-305DB16C-2320-42E9-A760-71ABDB8AE30DQ35618857-88396F52-796A-4E5B-BAB8-FD7213692E47Q35736188-B52F8880-9871-4660-84F4-06A716B8D662Q35768395-64BDC149-1AC1-413B-BE38-B44A95240C93Q35913571-A986F272-FC90-4058-9CEA-EEF4E4925E98Q36043159-3541A115-F10F-4447-868D-C8BA12BF257BQ36099731-130CD27B-557D-47B4-BFCD-CD7B28639279Q36178189-533B8250-D6FD-43DE-AAD2-90FFB16EA831Q36392466-E4ECE3F7-93A1-48E8-B38B-E237718BFF13Q36638226-79F8E4D3-368A-4E03-95AA-B6B270D26A7CQ36924465-F266E549-996E-4A9C-B146-4D592AC67175Q37025837-2EDD6E50-159C-4A43-A404-B94401EEC3CC
P2860
Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rare, evolutionarily unlikely ...... ncreased risk of breast cancer
@en
Rare, evolutionarily unlikely ...... creased risk of breast cancer.
@nl
type
label
Rare, evolutionarily unlikely ...... ncreased risk of breast cancer
@en
Rare, evolutionarily unlikely ...... creased risk of breast cancer.
@nl
prefLabel
Rare, evolutionarily unlikely ...... ncreased risk of breast cancer
@en
Rare, evolutionarily unlikely ...... creased risk of breast cancer.
@nl
P2093
P2860
P50
P1476
Rare, evolutionarily unlikely ...... ncreased risk of breast cancer
@en
P2093
Anne Hartmann
Australian Cancer Study
Barbara Herte
Breast Cancer Family Registries (BCFR)
Catherine Voegele
Corinna Feuchtinger
Davit Babikyan
Florence Le Calvez-Kelm
Janet Hall
Kathleen Cuningham Foundation ...... cts of Breast Cancer (kConFab)
P2860
P304
P356
10.1016/J.AJHG.2009.08.018
P407
P50
P577
2009-09-24T00:00:00Z